The Safety and Efficacy of Baclofen to Reduce Alcohol Use in Veterans with Chronic Hepatitis C: A Randomized Clinical Trial

CONCLUSIONSBaclofen administered at 30 mg/day does not appear to be superior to placebo in increasing abstinence or in reducing alcohol use, cravings for alcohol or anxiety among people with alcohol use disorder.

Source: Addiction - February 14, 2017 Category: Addiction Authors: Peter Hauser, Bret Fuller, Samuel B. Ho, Paul Thuras, Shira Kern, Eric Dieperink Tags: Research Report Source Type: research